Potential of CD80-transfected human breast carcinoma cells to induce peptide-specific T lymphocytes in an allogeneic human histocompatibility leukocyte antigens (HLA)-A2.1+-matched situation.

Meyer, G C; Batrla, R; Rudy, W; Meuer, S C; Wallwiener, D; Gückel, B; Moebius, U

Meyer, G C; Batrla, R; Rudy, W; Meuer, S C; Wallwiener, D; Gückel, B; Moebius, U.

Affiliation

Meyer GC; Research Group Gene Therapy of Tumors, German Cancer Research Center, Heidelberg. G.Meyer@DKFZ-Heidelberg.de

Cancer Gene Ther ; 6(3): 282-8, 1999.

Article in En | MEDLINE | ID: mdl-10359214

Subject(s)

B7-1 Antigen/genetics; Breast Neoplasms/therapy; HLA Antigens/genetics; T-Lymphocytes/metabolism; Cell Count; Humans; Immunoenzyme Techniques/methods; Interferon-gamma/pharmacology; Interleukin-2/pharmacology; Interleukin-4/pharmacology; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha/pharmacology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / T-Lymphocytes / B7-1 Antigen / HLA Antigens Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Gene Ther Journal subject: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Year: 1999 Type: Article

Search on Google

XML

PubMed Links